New York’s Shearman & Sterling acted as U.S. counsel to SmithKline Beecham P.L.C., and that city’s Sullivan & Cromwell was U.S. counsel to Glaxo Wellcome P.L.C., for their proposed $76 billion merger. Two London firms acted as primary outside counsel for the London-based drug makers: Slaughter & May for Glaxo Wellcome and Linklaters for SmithKline.

The Shearman attorneys are partners Stephen R. Volk, Creighton Condon, Linda E. Rappaport, Doreen Lilienfeld, Laurence M. Bambino in New York and, in Washington, D.C., Steven C. Sunshine; and associates Mark Roppel, Michael F. DeFranco, Jess Biggio and, in London, Michael B. Shulman.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]